US Bancorp’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-7,344
| Closed | -$624K | – | 3964 |
|
|
2020
Q3 | $624K | Sell |
7,344
-3,222
| -30% | -$163K | ﹤0.01% | 1214 |
|
|
2020
Q2 | $375K | Buy |
10,566
+908
| +9% | +$26.5K | ﹤0.01% | 1453 |
|
|
2020
Q1 | $130K | Buy |
9,658
+302
| +3% | +$5.08K | ﹤0.01% | 1894 |
|
|
2019
Q4 | $198K | Buy |
9,356
+2,607
| +39% | +$46K | ﹤0.01% | 1829 |
|
|
2019
Q3 | $90K | Hold |
6,749
| – | – | ﹤0.01% | 2215 |
|
|
2019
Q2 | $94K | Buy |
6,749
+2,423
| +56% | +$36.5K | ﹤0.01% | 2251 |
|
|
2019
Q1 | $83K | Buy |
4,326
+4,126
| +2,063% | +$66.5K | ﹤0.01% | 2283 |
|
|
2018
Q4 | $3K | Hold |
200
| – | – | ﹤0.01% | 3370 |
|
|
2018
Q3 | $4K | Hold |
200
| – | – | ﹤0.01% | 3392 |
|
|
2018
Q2 | $5K | Buy |
+200
| New | +$4.02K | ﹤0.01% | 3341 |
|
|
2017
Q2 | – | Sell |
-2,000
| Closed | -$13K | – | 3650 |
|
|
2017
Q1 | $13K | Buy |
+2,000
| New | +$10.1K | ﹤0.01% | 2980 |
|
US Bancorp's IMMU Position: Q4 2020 in Review
US Bancorp sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 7,344 shares — an estimated $624K sold.
US Bancorp first reported a position in IMMU in Q1 2017 and held it in 11 quarters. The position peaked at $624K in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- US Bancorp reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- US Bancorp sold 7,344 Immunomedics Inc shares in Q4 2020, an estimated $624K.
- US Bancorp first reported a position in Immunomedics Inc in Q1 2017 and held it in 11 quarters.
- US Bancorp's Immunomedics Inc position peaked at $624K in Q3 2020.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on US Bancorp's 13F filing for Q4 2020, filed 4 Feb 2021.